Skip to main content

Postdoc Portrait: Dinesh Kumar Reddy Medipally

Developing next-generation liquid biopsies, this postdoc blends spectroscopy and AI to improve cancer detection and prognosis.

Brought to you byThe Scientist
| 3 min read
A picture of Dinesh Kumar Reddy Medipally, a postdoc at the Technological University Dublin.
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Q | Write a brief introduction to yourself including the lab you work in and your research background.

I am Dinesh Medipally, an interdisciplinary scientist at the Centre for Radiation and Environmental Science, Technological University Dublin. My research focuses on developing innovative liquid biopsy technologies for cancer diagnosis and prognosis, integrating body fluid analysis, advanced spectroscopy, and artificial intelligence to enable accurate, non-invasive, and early disease detection.

Q | How did you first get interested in science and/or your field of research?

My interest in research began during my undergraduate studies, where I was fascinated by the intricate mechanisms of human biology and the potential to translate scientific discoveries into real-world health solutions. Early exposure to laboratory research deepened my curiosity, especially in understanding disease at the cellular and molecular levels. As I progressed through my academic career, I became particularly interested in cancer research, given its profound societal impact and the urgent need for improved diagnostic tools. This led me to explore interdisciplinary approaches, combining biology, analytical chemistry, spectroscopy, and later, artificial intelligence. I was drawn to the challenge of developing non-invasive, accurate, and rapid diagnostic methods that could improve patient outcomes and reduce healthcare burdens. Over the years, my passion has evolved into a commitment to advancing liquid biopsy technologies, where body fluid analysis is paired with advanced AI models for cancer diagnosis and prognosis. This integration of multiple disciplines allows me to innovate at the intersection of science, technology, and healthcare, driving my continued enthusiasm for impactful research.

Continue reading below...

Like this story? Sign up for FREE Cancer updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

Q | Tell us about your favorite research project you’re working on.

My favorite research project is “Development of Vibrational Spectroscopy of Liquid Biopsies for Prostate Cancer Detection and Prediction of Treatment Outcomes.” This work combined advanced vibrational spectroscopy techniques, body fluid analysis, and machine learning to improve cancer diagnosis and prognosis. Our findings demonstrated the potential of this technology as a powerful tool for early detection, treatment monitoring, and predicting outcomes in patients undergoing radiotherapy. The project resulted in several publications in reputed journals and has laid the groundwork for further advancements in this field, with the ultimate goal of achieving clinical translation. This research not only showcased the impact of integrating multidisciplinary approaches but also strengthened my commitment to developing innovative, non-invasive diagnostic technologies that can transform cancer care.

Q | What has been the most exciting part of your scientific career/journey so far?

The most exciting part of my scientific journey has been witnessing my research evolve from a conceptual idea to a validated technology with real-world potential. My work on developing vibrational spectroscopy-based liquid biopsies, combined with artificial intelligence, for the detection and prediction of prostate cancer outcomes, has been a defining milestone. Seeing the first results showing positive outcomes in detecting cancer and predicting treatment response was a moment of genuine excitement. It reflected the culmination of years of interdisciplinary effort across biology, spectroscopy, and machine learning. Equally thrilling was the professional recognition that followed, including securing highly competitive Irish research grants. These achievements not only validated the scientific merit of my work but also provided the resources to advance the technology towards clinical translation. Knowing that this research could one day enable earlier diagnosis, guide treatment decisions, and improve patient outcomes continues to fuel my passion and commitment to impactful, innovative science.

Q | If you could be a laboratory instrument, which one would you be and why?

If I could be a laboratory instrument, I would be a Raman spectrometer. Much like my own research philosophy, a Raman spectrometer is curious, precise, and thrives on uncovering hidden details. It works quietly yet powerfully, using light to reveal the molecular “fingerprints” of a sample without altering it, something I value in research: making an impact without causing harm. I admire its versatility. It can study anything from delicate biological samples to complex materials, mirroring my interdisciplinary approach that bridges biology, chemistry, and artificial intelligence. A Raman spectrometer is also future-focused, continuously finding new applications in medicine, environmental monitoring, and material science. If I were this instrument, I would take pride in helping researchers see the invisible, decode the complex, and make discoveries that could change lives, illuminating the path from fundamental science to transformative real-world solutions.

Are you a researcher who would like to be featured in the “Postdoc Portraits” series? Send in your application here.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays